On July 17, 2024, the U.S. Patent Office issued additional guidance regarding patentability and inventorship concerns relating to Artificial Intelligence.…
Read More →
On July 17, 2024—but just recently posted to the Office of Prescription Drug Promotion (OPDP) of the U.S. Food and…
Read More →
In March 2022, the In re Zostavax MDL court entered a Lone Pine order requiring plaintiffs who claimed to have…
Read More →
On July 30, 2024, Coastal Plains Community MHMR Center (“Coastal Plains”) filed a notice of data breach with the Attorney…
Read More →
Stellar defense work by Goldberg Segalla partner Christopher F. Lyon secured in New York County Supreme Court the dismissal of…
Read More →
The number of cases involving so-called “nuclear verdicts” — that is, verdicts with awards of $10 million or more —…
Read More →
The publication by the Joint Committee of the European Supervisory Authorities (ESAs) on (a) 17 July 2024 of the second…
Read More →
On July 24, 2024, the Commerce Department’s Bureau of Industry and Security (BIS) announced amendments to the U.S. Export Administration…
Read More →
Case Name: Salix Pharms., Ltd. v. Norwich Pharms. Inc., No. 2022-2153, 2023-1952, 2024 WL 1561195 (Fed. Cir. Apr. 11, 2024)…
Read More →
Precedential and Key Federal Circuit Opinions – 1. BACKERTOP LICENSING LLC [OPINION] (23-2367, 23-2368, 24-1016, 24-1017 Prost, Hughes, and Stoll) –…
Read More →